Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4B | Q07343 | 7/20 | 0.45 |
| ▸ | WNT3A | P56704 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.40 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.40 |
| ▸ | TCF7L2 | Q9NQB0 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | CCNE1 | P24864 | 1/20 | 0.39 |
| ▸ | CDK2 | P24941 | 1/20 | 0.39 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4144494 | 0.99 | PDE4B (0.44) | PDE4BWNT3AMEN1KMT2AEGLN1 | |
| SCHEMBL4141910 | 0.88 | TSHR (0.41) | PDE4BMEN1KMT2ALMNAADORA3 | |
| Hydrochloric Acid SCHEMBL4141904 | 0.87 | TSHR (0.40) | PDE4BMEN1KMT2ALMNAADORA3 | |
| Hydrochloric Acid SCHEMBL4144562 | 0.81 | EGLN1 (0.47) | PDE4BWNT3AMEN1KMT2AEGLN1 | |
| Hydrochloric Acid SCHEMBL4141946 | 0.80 | PDE4B (0.48) | PDE4BWNT3AMEN1KMT2AEGLN1 | |
| SCHEMBL4132365 | 0.73 | CCNE1 (0.49) | PDE4BWNT3AMEN1KMT2AADORA3 | |
| SCHEMBL6178282 | 0.72 | ELANE (0.51) | MEN1KMT2A | |
| SCHEMBL9551634 | 0.71 | CRHBP (0.60) | MEN1KMT2ANPC1LMNAPKM | |
| Hydrochloric Acid SCHEMBL4140741 | 0.71 | APP (0.53) | PDE4BMEN1KMT2ALMNAPKM | |
| SCHEMBL14719815 | 0.68 | ALDH1A1 (0.52) | MEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090005560-A1 | PRODUCTION METHOD OF DIAMINOPYRIMIDINE COMPOUNDS | AJINOMOTO CO. INC (JP) | 2009-01-01 | — | — | US | disclosed |
| EP-2009003-A1 | Production method of diaminopyrimidine compounds | Ajinomoto Co., Inc. (JP) | 2008-12-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090005560-A1 | PRODUCTION METHOD OF DIAMINOPYRIMIDINE COMPOUNDS | DPYD, DHPS, UMPS | PDE4B 119/4885WNT3A 3434/4885MEN1 2530/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.